Samsung Biopharmaceuticals and Teva Pharmaceuticals expand strategic cooperation to advance research and development of up to six candidate biosimilar drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.